Medical Cannabis Market 2019 Forecast Outlook by Pharmaceutical Companies, Medical Applications, Cannabinoids Product, Cannabis Revenue Growth & Regional Landscape

Medical Cannabis industry is still in its nascent stage & will develop significantly in the coming years. Increasing use of marijuana in therapeutic applications such as pain management in neurology, cancer, HIV/AIDS, seizures, & nausea will drive the medical cannabis market growth

Dallas, United States - August 14, 2019 /MarketersMedia/ —

The research report on ‘global medical cannabis market’ provides a detailed market analysis with market share and major players operating in the market. The report also covers the comprehensive outlook of technology, product specification, production analysis, and product type with the help of some key factors such as gross margin, cost, and revenue. The global medical cannabis market report offers in-depth study market segmentation depending on several regions. The report also contains the qualitative and quantitative analysis of market players.

Get Research Insights @ Global Medical Cannabis Market Research Report

Global medical cannabis market size is valued at US$ 7.26 billion from US$ 56.70 billion at a recorded CAGR of 29.3% over the forecast period. Increasing countries approving the utilization of cannabis, increasing edible products, and rising Research & Development activities are fueling the global medical cannabis market growth. In addition, rising growth of therapies with cannabis expected to drive the global medical cannabis market growth.

The global medical cannabis market segmentation is done with the help of indication and geographical regions. By indication, the global medical cannabis market is divided into neurological disease, pain management, and many others. However, the pain management segment is accounted for the highest global medical cannabis market share of 60%, and it is likely to dominate its growth over the forecast period. Many patients with lasting disorders need medical cannabis and it is anticipated to boost the global medical cannabis market growth during the prediction period. Likewise, medical cannabis shows positive results in number of chronic diseases such as Alzheimer’s, Parkinson’s, and Epilepsy.

Medical Cannabis Market Size by Indication (Pain Management, Neurological disorders, and others) by Region and Forecast 2016 to 2026 @ https://www.adroitmarketresearch.com/industry-reports/medical-cannabis-market

Based on regional landscape, the global medical cannabis market is sub-segmented into the North America, Asia Pacific, Europe, MEA, and Central & South America. In between these, the North America region dominated for the highest global medical cannabis market share over the forecast period. However, Canada and United States are major regions which authorized medical cannabis with maximum number of consumers. Increased awareness about medical usage and its benefits in chronic disease are projected to rise rapidly than the North American market.

North America dominates the global medical cannabis market by contributing over 90% of total revenue, of which majority comes from the U.S. Additionally, legalization in Canada is expected to grow at a faster CAGR compared to the U.S., on account of growth phase of Canadian market. The total number of patients using medical cannabis in Canada has increased in the past few quarters with corresponding increase in the number of licensed producers. This increase in number of medical cannabis users has led to a spike in revenues for companies. Such prevailing dynamics in the Canadian market is expected to attract investors in the coming years.

The global medical cannabis market is highly competitive owing to the large number of leading competitors playing in the market. These players are trying to stand their position in the global as well as local market. They use several strategies such as merger & acquisition, new product launches, and R&D activities. Some top players operating in this market are Maricann Group, Inc., Aphria, Inc., ABcann Medicinals, GW Pharmaceuticals, Organigram Holding, Inc., and Lexaria Corp.

Make an Enquire to Buy This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/864

Key Segments of the Global Medical Cannabis Market

Indication Overview, 2016-2026 (USD Billion)
• Pain Management
• Neurological Disease
• Others

Regional Overview, 2015-2025 (USD Million)
• North America
• U.S.
• Canada
• Europe
• Germany
• Spain
• Italy
• Asia Pacific
• Australia
• New Zealand
• Central & South America
• Mexico
• Uruguay
• Middle East & Africa

Buy the report @ https://www.adroitmarketresearch.com/researchreport/purchase/864

Major points from Table of Contents:

Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. Medical cannabis Market Overview, By Indication
Chapter 5. Key Country Market
Chapter 6. Company Profiles

Grasp advance knowledge on Global Medical Cannabis Industry through in-depth Blogs, White Paper & Infographics:

Access the Blog: “Medical Cannabis Helpful For Insomnia Patients

Across North America sleep disorders are very common now. Actually, many of the approximations are suggesting one in four Canadians suffering from insomnia, making it a common disorder of sleep.

Access the White Paper “All You Need To Know About Medical Cannabis

Recent United States Cannabis Research and Policy & Law Cannabis has validated health benefits since past few years. However, less than 6% of current studies on marijuana investigate its medical properties, periodicals to date specify that cannabis shows promise for the treatment of several diseases and symptoms. Though, patients with cancer and chronic pain, for ex. have been blocked from such benefits since the mid-20th century when government regulations were sanctioned that banned the sales, use, and distribution of cannabis due to its psychoactive properties.

About Adroit Market Research:

Adroit Market Research provide quantified B2B research on numerous opportunistic markets, and offer customized research reports, consulting services, and syndicate research reports. We assist our clients to strategize business decisions and attain sustainable growth in their respective domain. Additionally, we support them with their revenue planning, marketing strategies, and assist them to make decisions before the competition so that they remain ahead of the curve.

Contact Info:
Name: Ryan Johnson
Email: Send Email
Organization: Adroit Market Research
Address: 3131 McKinney Ave Ste 600 Dallas, TX 75204, U.S.A
Phone: +1 972-362 -8199
Website: https://www.adroitmarketresearch.com/industry-reports/medical-cannabis-market

Source URL: https://marketersmedia.com/medical-cannabis-market-2019-forecast-outlook-by-pharmaceutical-companies-medical-applications-cannabinoids-product-cannabis-revenue-growth-regional-landscape/88907320

Source: MarketersMedia

Release ID: 88907320

Latest News

Panel approves ban on sale of flavored e-cigs in New York

Sep 19, 2019

NEW YORK — New York became the first state to ban the sale of flavored e-cigarettes Tuesday, a move that comes as federal health officials investigate a mysterious surge of severe breathing illnesses linked to vaping. The vote by the state Public Health and Health Planning Council means the prohibition, which covers flavored e-cigarettes and other vaping products except for menthol and tobacco flavors, goes into effect immediately. Retailers will have two weeks to remove merchandise from store shelves. Gov. Andrew Cuomo, a Democrat, had proposed the emergency ban Sunday , citing surging use among young people. According to data...

Democrats push ahead with short-term bill to avoid shutdown

Sep 19, 2019

WASHINGTON — Democrats controlling the House are steering clear of controversy in a short-term, government-wide spending measure that's needed to prevent a government shutdown at the end of September. House Speaker Nancy Pelosi has agreed to a White House request to replenish funds for bailout payments to farmers absorbing heavy losses as a result of President Donald Trump's trade battles with China. She has also rejected suggestions from House liberals to try to use the must-pass stopgap measure to try to reverse the president's controversial moves to raid military base construction projects to pay for the border wall, The temporary...

EPA set to end California's ability to regulate fuel economy

Sep 19, 2019

WASHINGTON — The Trump administration is poised to revoke California's authority to set auto mileage standards, asserting that only the federal government has the power to regulate greenhouse gas emissions and fuel economy. Conservative and free-market groups have been asked to attend a formal announcement of the rollback set for Wednesday afternoon at Environmental Protection Agency headquarters in Washington. Gloria Bergquist, spokeswoman for the Alliance of Automobile Manufacturers, said Tuesday that her group was among those invited to the event featuring EPA Administrator Andrew Wheeler and Transportation Secretary Elaine Chao. The move comes after the Justice Department recently opened an...

Protest likely to greet Trump fundraising trip in California

Sep 19, 2019

RIO RANCHO, N.M. — President Donald Trump is making a rare visit to California, a Democratic stronghold where he is expected to rake in millions of dollars during a series of fundraisers for his reelection effort that are almost certain to be met with jeering protests. Trump has routinely mocked California over its liberal culture, policies and politics. His visit Tuesday and Wednesday signals that despite the state's decidedly leftward swing in recent years there are still plenty of wealthy Republicans who support him. "There's not been a president in living history that is as unpopular in the state of...

Japanese officials cautious on prospects for US trade deal

Sep 19, 2019

TOKYO — Officials in Japan appeared wary over the prospects for a trade deal with the U.S. after President Donald Trump said he was prepared to sign a pact soon. Japan's chief government spokesman, Yoshihide Suga, said Tuesday that the two sides are still finalizing details after reaching a basic agreement in late August on trade in farm products, digital trade and other industries. Suga said Trump and Prime Minister Shinzo Abe are considering signing a deal in late September when they attend the U.N. General Assembly in New York. "We are accelerating the work that still remains," he said....

Search
Financial Markets

About Us

Established in 2015, The Upstocker provides insights on financial reports, commentary, and investment data to traders so that you can make better investment decisions.

Contact us: sales[at]theupstocker.com

Subscribe Now!